David Lebwohl, EVP, Chief Medical Officer at Intellia Therapeutics, Inc. (NTLA), sold 19,114 shares at $12.18 ($233K) on 2025-01-03, disclosed to the SEC on 2025-01-07.
Open-market sale of $233k NTLA by EVP, Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.18 | 9,557 | $116K | 50.0% |
| 2 | $12.18 | 9,557 | $116K | 50.0% |
| Total | $12.18 avg | 19,114 | $233K | 100% |
| Filing → |
| NTLA | SELL | 2023-01-06 | $192K | — | Filing → |
| NTLA | SELL | 2022-03-03 | $236K | — | Filing → |
| NTLA | SELL | 2021-11-09 | $452K | — | Filing → |